Evolent Health, Inc which can be found using ticker (EVH) now have 8 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 63 and 36 calculating the average target price we see $47.00. Now with the previous closing price of $35.36 this is indicating there is a potential upside of 32.9%. The 50 day moving average now sits at $32.82 and the 200 day MA is $31.96. The total market capitalization for the company now stands at $3,918m. Company Website: https://www.evolenthealth.com
The potential market cap would be $5,208m based on the market consensus.
Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
The company is not paying dividends at this time.
